BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wakai T, Shirai Y, Moroda T, Yokoyama N, Hatakeyama K. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005;103:1210-1216. [PMID: 15685618 DOI: 10.1002/cncr.20906] [Cited by in Crossref: 166] [Cited by in F6Publishing: 150] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nagino M. Hepatopancreatoduodenectomy for anastomotic recurrence from residual cholangiocarcinoma: report of a case. Surg Today 2014;44:952-6. [PMID: 23702706 DOI: 10.1007/s00595-013-0578-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Schlitter AM, Esposito I. Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancers (Basel). 2010;2:2001-2010. [PMID: 24281214 DOI: 10.3390/cancers2042001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
3 Peng S, Zhang Y, Peng H, Ke Z, Xu L, Su T, Tsung A, Tohme S, Huang H, Zhang Q, Lencioni R, Zeng Z, Peng B, Chen M, Kuang M. Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib. Cancer Lett. 2016;373:193-202. [PMID: 26805764 DOI: 10.1016/j.canlet.2016.01.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 6.2] [Reference Citation Analysis]
4 Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Miyagawa S. Surgical Treatment of 144 Cases of Hilar Cholangiocarcinoma Without Liver-Related Mortality. World J Surg 2014;38:1164-76. [DOI: 10.1007/s00268-013-2394-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
5 Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nagino M. Review of hepatopancreatoduodenectomy for biliary cancer: an extended radical approach of Japanese origin. J Hepatobiliary Pancreat Sci. 2014;21:550-555. [PMID: 24464987 DOI: 10.1002/jhbp.80] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
6 Higuchi R, Yazawa T, Uemura S, Izumo W, Furukawa T, Yamamoto M. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study. J Hepatobiliary Pancreat Sci 2017;24:456-65. [DOI: 10.1002/jhbp.481] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
7 Endo I, House MG, Klimstra DS, Gönen M, D'Angelica M, Dematteo RP, Fong Y, Blumgart LH, Jarnagin WR. Clinical significance of intraoperative bile duct margin assessment for hilar cholangiocarcinoma. Ann Surg Oncol 2008;15:2104-12. [PMID: 18543039 DOI: 10.1245/s10434-008-0003-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
8 Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, Ben-Josef E. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2006;66:772-779. [PMID: 17011452 DOI: 10.1016/j.ijrobp.2006.05.061] [Cited by in Crossref: 84] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
9 Komaya K, Ebata T, Shirai K, Ohira S, Morofuji N, Akutagawa A, Yamaguchi R, Nagino M; Nagoya Surgical Oncology Group. Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg. 2017;104:426-433. [PMID: 28138968 DOI: 10.1002/bjs.10452] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
10 Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y, Nagino M; Nagoya Surgical Oncology Group. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg. 2015;102:399-406. [PMID: 25611179 DOI: 10.1002/bjs.9752] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 12.1] [Reference Citation Analysis]
11 Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2013;257:718-725. [PMID: 23407295 DOI: 10.1097/sla.0b013e3182822277] [Cited by in Crossref: 85] [Cited by in F6Publishing: 28] [Article Influence: 9.4] [Reference Citation Analysis]
12 Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach. Surgery 2018;163:732-8. [PMID: 29336813 DOI: 10.1016/j.surg.2017.08.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
13 Nakanishi Y, Kondo S, Zen Y, Yonemori A, Kubota K, Kawakami H, Tanaka E, Hirano S, Itoh T, Nakanuma Y. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:166-73. [DOI: 10.1007/s00534-009-0127-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Ohtsuka M, Miyakawa S, Nagino M, Takada T, Miyazaki M. Revision concepts and distinctive points of the new Japanese classification for biliary tract cancers in comparison with the 7 th edition of the Union for International Cancer Control and the American Joint Committee on Cancer staging system: ▪. J Hepatobiliary Pancreat Sci 2015;22:197-201. [DOI: 10.1002/jhbp.212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
16 Choi SB, Park SW, Kim KS, Choi JS, Lee WJ. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol. 2009;99:335-342. [PMID: 19226533 DOI: 10.1002/jso.21238] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
17 Saikusa N, Naito S, Iinuma Y, Ohtani T, Yokoyama N, Nitta K. Invasive cholangiocarcinoma identified in congenital biliary dilatation in a 3-year-old boy. Journal of Pediatric Surgery 2009;44:2202-5. [DOI: 10.1016/j.jpedsurg.2009.06.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
18 Nishio H, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953-960. [PMID: 21490453 DOI: 10.1097/sla.0b013e318216f5f3] [Cited by in Crossref: 64] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
19 Park MJ, Kim YK, Lim S, Rhim H, Lee WJ. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation. Radiology. 2014;270:768-776. [PMID: 24475800 DOI: 10.1148/radiol.13130009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
20 Boutros C, Somasundar P, Espat NJ. Extrahepatic Cholangiocarcinoma: Current Surgical Strategy. Surgical Oncology Clinics of North America 2009;18:269-88. [DOI: 10.1016/j.soc.2008.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malagó M, Broelsch CE. [Surgical therapy of hilar cholangiocarcinoma]. Chirurg 2006;77:325-34. [PMID: 16568258 DOI: 10.1007/s00104-006-1177-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
22 Han IW, Jang JY, Lee KB, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) 2014;16:575-81. [PMID: 24308425 DOI: 10.1111/hpb.12193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
23 Mogler C, Flechtenmacher C, Schirmacher P, Bergmann F. [Frozen section diagnostics in visceral surgery. Liver, bile ducts and pancreas]. Pathologe 2012;33:413-23. [PMID: 22892660 DOI: 10.1007/s00292-012-1602-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Matsumoto N, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma. Br J Surg. 2014;101:261-268. [PMID: 24399779 DOI: 10.1002/bjs.9383] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
25 Nagahashi M, Shirai Y, Wakai T, Sakata J, Ajioka Y, Nomura T, Tsuchiya Y, Hatakeyama K. Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma. Cancer. 2010;116:400-405. [PMID: 19950133 DOI: 10.1002/cncr.24766] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
26 Nakanishi Y, Kondo S, Hirano S, Ambo Y, Tanaka E, Morikawa T, Itoh T. Recurrence of mucosal carcinoma of the bile duct, with superficial flat spread, 12 years after operation. J Hepatobiliary Pancreat Surg. 2006;13:355-358. [PMID: 16858550 DOI: 10.1007/s00534-006-1092-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
27 Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007;31:1788-1796. [PMID: 17647056 DOI: 10.1007/s00268-007-9102-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 5.0] [Reference Citation Analysis]
28 Buchner D, Drebber U, Chang DH, Stippel DL. Bile duct carcinoma recurrence in the papillary region in a long-term survivor of hilar cholangiocarcinoma: a case report. J Med Case Rep 2016;10:299. [PMID: 27784337 DOI: 10.1186/s13256-016-1073-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Wakai T, Sakata J, Katada T, Hirose Y, Soma D, Prasoon P, Miura K, Kobayashi T. Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg 2018;2:359-66. [PMID: 30238077 DOI: 10.1002/ags3.12196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
30 Kim BH, Chie EK, Kim K, Jang JY, Kim SW, Oh DY, Bang YJ, Ha SW. Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution. Oncotarget 2017;8:78076-85. [PMID: 29100449 DOI: 10.18632/oncotarget.17368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
31 Ke Q, Wang B, Lin N, Wang L, Liu J. Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis. World J Surg Oncol 2019;17:211. [PMID: 31818290 DOI: 10.1186/s12957-019-1749-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22:249-273. [PMID: 25787274 DOI: 10.1002/jhbp.233] [Cited by in Crossref: 138] [Cited by in F6Publishing: 110] [Article Influence: 19.7] [Reference Citation Analysis]
33 Castellano-Megías VM, Ibarrola-de Andrés C, Colina-Ruizdelgado F. Pathological aspects of so called "hilar cholangiocarcinoma". World J Gastrointest Oncol 2013; 5(7): 159-170 [PMID: 23919110 DOI: 10.4251/wjgo.v5.i7.159] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
34 Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Ohtsuka T, Yoshizumi T, Aishima S, Oda Y, Honda H. Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma. Eur Radiol 2017;27:2563-9. [DOI: 10.1007/s00330-016-4621-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
35 Tone K, Kojima K, Hoshiai K, Kijima H, Kurose A. Utility of intraoperative cytology of resection margins in biliary tract and pancreas tumors. Diagn Cytopathol 2015;43:366-73. [PMID: 25476547 DOI: 10.1002/dc.23240] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Lee SJ, Hwang S, Ha TY, Kim KH, Ahn CS, Moon DB, Song GW, Jung DH, Park GC, Lee SG. Technical knacks and outcomes of extended extrahepatic bile duct resection in patients with mid bile duct cancer. Korean J Hepatobiliary Pancreat Surg 2013;17:109-12. [PMID: 26155223 DOI: 10.14701/kjhbps.2013.17.3.109] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Bickenbach KA, Shia J, Klimstra DS, DeMatteo RP, Fong Y, Kingham TP, Allen PJ, Jarnagin WR, D'Angelica MI. High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy. HPB (Oxford) 2011;13:865-8. [PMID: 22081921 DOI: 10.1111/j.1477-2574.2011.00388.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
38 Onoyama T, Matsumoto K, Takeda Y, Kawata S, Kurumi H, Koda H, Yamashita T, Takata T, Isomoto H. Endoscopic Ultrasonography-Guided Fine Needle Aspiration for Extrahepatic Cholangiocarcinoma: A Safe Tissue Sampling Modality. J Clin Med 2019;8:E417. [PMID: 30934706 DOI: 10.3390/jcm8040417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
39 Ebata T, Mizuno T, Yokoyama Y, Igami T, Yamaguchi J, Onoe S, Watanabe N, Nagino M. Predictive performance of Blumgart T staging for perihilar cholangiocarcinoma in a Japanese center. J Hepatobiliary Pancreat Sci 2020;27:132-40. [PMID: 31654600 DOI: 10.1002/jhbp.694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
40 Herman JM, Pawlik TM. Hepatocellular Carcinoma, Gallbladder Cancer, and Cholangiocarcinoma. In: Lu JJ, Brady LW, editors. Radiation Oncology. Berlin: Springer Berlin Heidelberg; 2008. pp. 221-43. [DOI: 10.1007/978-3-540-77385-6_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Shinohara K, Ebata T, Shimoyama Y, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma. Annals of Surgery 2021;273:572-8. [DOI: 10.1097/sla.0000000000003305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
42 Regimbeau J, Fuks D, Chatelain D, Riboulot M, Delcenserie R, Yzet T. Prise en charge chirurgicale du cholangiocarcinome hilaire résécable. Gastroentérologie Clinique et Biologique 2008;32:620-31. [DOI: 10.1016/j.gcb.2008.04.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Ebata T, Mizuno T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. Br J Surg. 2018;105:829-838. [PMID: 28488733 DOI: 10.1002/bjs.10556] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 9.4] [Reference Citation Analysis]
44 Washington MK. Gallbladder and Extrahepatic Bile Ducts. Modern Surgical Pathology. Elsevier; 2009. pp. 960-75. [DOI: 10.1016/b978-1-4160-3966-2.00028-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Kim YS, Jeong CY, Song HN, Kim TH, Kim HJ, Lee YJ, Hong SC. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection. Chin J Cancer 2017;36:9. [PMID: 28086990 DOI: 10.1186/s40880-017-0182-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
46 Ojima H, Kanai Y, Iwasaki M, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Sakamoto M, Hirohashi S. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 2009;100:62-70. [PMID: 19038006 DOI: 10.1111/j.1349-7006.2008.01009.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
47 Seyama Y, Kokudo N, Makuuchi M. Radical Resection of Biliary Tract Cancers and the Role of Extended Lymphadenectomy. Surgical Oncology Clinics of North America 2009;18:339-59. [DOI: 10.1016/j.soc.2008.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Kato Y, Takahashi S, Gotohda N, Konishi M. Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer. J Gastrointest Surg 2016;20:1435-43. [PMID: 27250990 DOI: 10.1007/s11605-016-3180-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
49 Yoshida N, Aoyagi T, Kimura Y, Naito Y, Izuwa A, Mizoguchi K, Ishii K, Tanaka Y, Ohnishi E, Miura S, Shimamura S, Shirahama N, Kaneshiro K, Saruwatari A, Iwanaga A, Sadakari Y, Hirokata G, Ogata T, Taniguchi M. A rare case of symptomatic grossly-visible biliary intraepithelial neoplasia mimicking cholangiocarcinoma. World J Surg Oncol 2019;17:191. [PMID: 31711502 DOI: 10.1186/s12957-019-1737-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Jikei K, Ebata T, Mizuno T, Kyokane T, Matsubara H, Yokoyama S, Kato K, Suzumura K, Hashimoto M, Kawai S, Nagino M; Nagoya Surgical Oncology Group. Oncologic Reappraisal of Bile Duct Resection for Middle-Third Cholangiocarcinoma. Ann Surg Oncol 2021;28:1990-9. [PMID: 32960392 DOI: 10.1245/s10434-020-09157-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Igami T, Nagino M, Oda K, Nishio H, Ebata T, Yokoyama Y, Shimoyama Y. Clinicopathologic Study of Cholangiocarcinoma With Superficial Spread. Annals of Surgery 2009;249:296-302. [DOI: 10.1097/sla.0b013e318190a647] [Cited by in Crossref: 111] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
52 Yamashita S, Passot G, Aloia TA, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer. Br J Surg 2017;104:267-77. [PMID: 28052308 DOI: 10.1002/bjs.10415] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
53 Kang MJ, Jang JY, Chang J, Shin YC, Lee D, Kim HB, Kim SW. Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma. World J Surg. 2016;40:2451-2459. [PMID: 27206402 DOI: 10.1007/s00268-016-3551-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
54 Park Y, Kim K, Paik JH, Chie EK, Jang JY, Kim SW, Oh DY. High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients. Eur J Surg Oncol 2018;44:638-43. [PMID: 29422250 DOI: 10.1016/j.ejso.2018.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Ye XW, Hu HJ, Xiong XZ, Lu J, Cheng NS. The preoperative elevated plasma fibrinogen level is associated with the prognosis of hilar cholangiocarcinoma. Surg Today 2021;51:1352-60. [PMID: 33651221 DOI: 10.1007/s00595-021-02249-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Maeta T, Ebata T, Hayashi E, Kawahara T, Mizuno S, Matsumoto N, Ohta S, Nagino M; Nagoya Surgical Oncology Group. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma. Br J Surg 2017;104:1549-57. [PMID: 28782798 DOI: 10.1002/bjs.10596] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
57 Higuchi R, Ota T, Araida T, Kobayashi M, Furukawa T, Yamamoto M. Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery. 2010;148:7-14. [PMID: 20116818 DOI: 10.1016/j.surg.2009.11.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
58 Park Y, Hwang DW, Kim JH, Hong SM, Jun SY, Lee JH, Song KB, Jun ES, Kim SC, Park KM. Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection. J Hepatobiliary Pancreat Sci. 2019;26:169-178. [PMID: 30849218 DOI: 10.1002/jhbp.619] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
59 Nakanishi Y, Zen Y, Kawakami H, Kubota K, Itoh T, Hirano S, Tanaka E, Nakanuma Y, Kondo S. Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Mod Pathol. 2008;21:807-816. [PMID: 18425077 DOI: 10.1038/modpathol.2008.65] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
60 Hijioka S, Hara K, Mizuno N, Imaoka H, Mekky MA, Nagashio Y, Sekine M, Tajika M, Tanaka T, Ishihara M, Hosoda W, Yatabe Y, Shimizu Y, Niwa Y, Yamao K. A novel technique for endoscopic transpapillary "mapping biopsy specimens" of superficial intraductal spread of bile duct carcinoma (with videos). Gastrointest Endosc 2014;79:1020-5. [PMID: 24674353 DOI: 10.1016/j.gie.2014.01.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
61 Shiraki T, Kuroda H, Takada A, Nakazato Y, Kubota K, Imai Y. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma. World J Gastroenterol 2018; 24(12): 1332-1342 [PMID: 29599608 DOI: 10.3748/wjg.v24.i12.1332] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
62 Lenet T, Gilbert RWD, Smoot R, Tzeng CD, Rocha FG, Yohanathan L, Cleary SP, Martel G, Bertens KA. Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis. Ann Surg Oncol 2022. [PMID: 35752725 DOI: 10.1245/s10434-022-12041-x] [Reference Citation Analysis]
63 Shin D, Lee S, Lee JH, Hong SM, Park SY, Yoo C, Lee W, Song KB, Hwang DW, Kim SC. Prognostic implication of high grade biliary intraepithelial neoplasia in bile duct resection margins in patients with resected perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2020;27:604-13. [PMID: 32639085 DOI: 10.1002/jhbp.800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Hayashi A, Aishima S, Inoue T, Nakata K, Morimatsu K, Nagai E, Oda Y, Tanaka M, Tsuneyoshi M. Decreased expression of focal adhesion kinase is associated with a poor prognosis in extrahepatic bile duct carcinoma. Hum Pathol 2010;41:859-66. [PMID: 20185162 DOI: 10.1016/j.humpath.2009.09.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
65 Shinohara K, Ebata T, Shimoyama Y, Nakaguro M, Mizuno T, Matsuo K, Nagino M. Proposal for a new classification for perihilar cholangiocarcinoma based on tumour depth. British Journal of Surgery 2019;106:427-35. [DOI: 10.1002/bjs.11063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
66 Sugiura T, Uesaka K, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Asakura H, Todaka A, Fukutomi A. Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma. Ann Gastroenterol Surg 2020;4:455-63. [PMID: 32724890 DOI: 10.1002/ags3.12345] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Konishi M, Ochiai A, Ojima H, Hasebe T, Mano M, Ohta T, Ito I, Sasaki K, Yasukawa S, Shimada K, Iwasaki M, Yanagisawa A. A new histological classification for intra-operative histological examination of the ductal resection margin in cholangiocarcinoma. Cancer Science 2009;100:255-60. [DOI: 10.1111/j.1349-7006.2008.01043.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
68 Toyoda Y, Ebata T, Mizuno T, Yokoyama Y, Igami T, Yamaguchi J, Onoe S, Watanabe N, Nagino M. Cholangiographic Tumor Classification for Simple Patient Selection Prior to Hepatopancreatoduodenectomy for Cholangiocarcinoma. Ann Surg Oncol. 2019;26:2971-2979. [PMID: 31102092 DOI: 10.1245/s10434-019-07457-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Akamatsu N, Sugawara Y, Osada H, Okada T, Itoyama S, Komagome M, Shin N, Cho N, Ishida T, Ozawa F, Hashimoto D. Diagnostic accuracy of multidetector-row computed tomography for hilar cholangiocarcinoma. J Gastroenterol Hepatol 2010;25:731-7. [PMID: 20074166 DOI: 10.1111/j.1440-1746.2009.06113.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
70 Prasad GA, Wang KK, Baron TH, Buttar NS, Wongkeesong LM, Roberts LR, LeRoy AJ, Lutzke LS, Borkenhagen LS. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol. 2007;5:743-748. [PMID: 17545000 DOI: 10.1016/j.cgh.2007.02.021] [Cited by in Crossref: 53] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
71 Kosar I, Ataseven H, Yönem O, Cakmak E, Ozer O, Ozer H, Topçu O. A new variant of bile duct duplication with coexistence of distal cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2010;7:527-30. [PMID: 20703236 DOI: 10.1038/nrgastro.2010.118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
72 Kato M, Onoyama T, Takeda Y, Kawata S, Kurumi H, Koda H, Yamashita T, Hamamoto W, Sakamoto Y, Matsumoto K, Isomoto H. Peroral Cholangioscopy-Guided Forceps Biopsy and Endoscopic Scraper for the Diagnosis of Indeterminate Extrahepatic Biliary Stricture. J Clin Med 2019;8:E873. [PMID: 31248095 DOI: 10.3390/jcm8060873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Aitken K, Hawkins M. The Role of Radiotherapy and Chemoradiation in the Management of Primary Liver Tumours. Clinical Oncology 2014;26:569-80. [DOI: 10.1016/j.clon.2014.05.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
74 Jung P, Cho EH, Kim SB, Kim RG. Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2019;23:319-26. [PMID: 31824996 DOI: 10.14701/ahbps.2019.23.4.319] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Ito Y, Abe Y, Egawa T, Kitago M, Itano O, Kitagawa Y. Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy. Gastroenterol Res Pract 2018;2018:6431254. [PMID: 29849596 DOI: 10.1155/2018/6431254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
76 Kanno Y, Koshita S, Ogawa T, Masu K, Kusunose H, Sakai T, Murabayashi T, Haegawa S, Kozakai F, Yonamine K, Kawakami Y, Fujii Y, Horaguchi J, Noda Y, Ito K. Peroral cholangioscopy by SpyGlass DS versus CHF-B260 for evaluation of the lateral spread of extrahepatic cholangiocarcinoma. Endosc Int Open 2018;6:E1349-54. [PMID: 30410956 DOI: 10.1055/a-0743-5283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
77 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
78 Ito T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Shimoyama Y, Nagino M. The pathologic correlation between liver and portal vein invasion in perihilar cholangiocarcinoma: evaluating the oncologic rationale for the American Joint Committee on Cancer definitions of T2 and T3 tumors. World J Surg 2014;38:3215-21. [PMID: 25123177 DOI: 10.1007/s00268-014-2719-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
79 Esposito I, Schirmacher P. Pathological aspects of cholangiocarcinoma. HPB (Oxford). 2008;10:83-86. [PMID: 18773061 DOI: 10.1080/13651820801992609] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
80 Tsukahara T, Ebata T, Shimoyama Y, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nagino M. Residual Carcinoma In Situ at the Ductal Stump has a Negative Survival Effect: An Analysis of Early-stage Cholangiocarcinomas. Annals of Surgery 2017;266:126-32. [DOI: 10.1097/sla.0000000000001944] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
81 Chauhan A, House MG, Pitt HA, Nakeeb A, Howard TJ, Zyromski NJ, Schmidt CM, Ball CG, Lillemoe KD. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma. HPB (Oxford). 2011;13:139-147. [PMID: 21241432 DOI: 10.1111/j.1477-2574.2010.00262.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
82 Wakai T, Shirai Y, Sakata J, Korita PV, Ajioka Y, Hatakeyama K. Early DNA damage response in residual carcinoma in situ at ductal stumps and local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2013;20:362-9. [PMID: 22886457 DOI: 10.1007/s00534-012-0539-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
83 Lee J, Kang SH, Noh OK, Chun M, Oh YT, Kim BW, Kim SW. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma. Clin Transl Oncol. 2018;20:1011-1017. [PMID: 29256155 DOI: 10.1007/s12094-017-1815-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
84 Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Oh DY, Bang YJ. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution. Cancer Res Treat 2017;49:473-83. [PMID: 27554480 DOI: 10.4143/crt.2016.166] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
85 Kato H, Tabata M, Azumi Y, Osawa I, Kishiwada M, Hamada T, Mizuno S, Usui M, Sakurai H, Isaji S. Proposal for a morphological classification of intraductal papillary neoplasm of the bile duct (IPN-B). J Hepatobiliary Pancreat Sci. 2013;20:165-172. [PMID: 22426592 DOI: 10.1007/s00534-012-0513-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
86 Machimoto T, Doi R, Ogawa K, Masui T, Seo S, Uemoto S. Abdominal wall recurrence of Hilar bile duct cancer 12 years after a curative resection: report of a case. Surg Today 2009;39:72-6. [PMID: 19132474 DOI: 10.1007/s00595-008-3791-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
87 Lim KH, Oh DY, Chie EK, Jang JY, Im SA, Kim TY, Kim SW, Ha SW, Bang YJ. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study. BMC Cancer. 2009;9:345. [PMID: 19781103 DOI: 10.1186/1471-2407-9-345] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
88 Sakata J, Nomura T, Aono T, Kitami C, Yokoyama N, Minagawa M, Takizawa K, Miura K, Hirose Y, Ichikawa H, Nagahashi M, Shimada Y, Kobayashi T, Wakai T. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates? HPB (Oxford) 2021:S1365-182X(21)00016-2. [PMID: 33558069 DOI: 10.1016/j.hpb.2021.01.007] [Reference Citation Analysis]
89 Sugiyama H, Tsuyuguchi T, Sakai Y, Ohtsuka M, Miyazaki M, Yokosuka O. Potential role of peroral cholangioscopy for preoperative diagnosis of cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech 2012;22:532-6. [PMID: 23238382 DOI: 10.1097/SLE.0b013e3182686178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
90 Peng H, Zhang Q, Li J, Zhang N, Hua Y, Xu L, Deng Y, Lai J, Peng Z, Peng B. Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma. Oncotarget. 2016;7:17220-17229. [PMID: 26967384 DOI: 10.18632/oncotarget.7948] [Cited by in Crossref: 63] [Cited by in F6Publishing: 80] [Article Influence: 12.6] [Reference Citation Analysis]
91 Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ. Prognostic factors in patients with middle and distal bile duct cancers. World J Gastroenterol 2014; 20(21): 6658-6665 [PMID: 24914391 DOI: 10.3748/wjg.v20.i21.6658] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
92 Wakai T, Shirai Y, Tsuchiya Y, Nomura T, Akazawa K, Hatakeyama K. Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results. World J Surg. 2008;32:1067-1074. [PMID: 18231828 DOI: 10.1007/s00268-007-9393-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 4.2] [Reference Citation Analysis]
93 Furukawa T, Higuchi R, Yamamoto M. Clinical relevance of frozen diagnosis of ductal margins in surgery of bile duct cancer. J Hepatobiliary Pancreat Sci 2014;21:459-62. [PMID: 24446432 DOI: 10.1002/jhbp.73] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
94 Kawai M, Tani M, Kobayashi Y, Tsuji T, Tabuse K, Horiuchi T, Oka M, Yamaguchi K, Sakata Y, Shimomura T. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Am J Surg. 2010;199:447-452. [PMID: 19596119 DOI: 10.1016/j.amjsurg.2009.01.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
95 Shiihara M, Higuchi R, Morita S, Furukawa T, Yazawa T, Uemura S, Izumo W, Yamamoto M. Diagnosis by 64-Row Multidetector Computed Tomography for Longitudinal Superficial Extension of Distal Cholangiocarcinoma. J Surg Res 2019;235:487-93. [PMID: 30691833 DOI: 10.1016/j.jss.2018.10.045] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Otsuka S, Ebata T, Yokoyama Y, Mizuno T, Tsukahara T, Shimoyama Y, Ando M, Nagino M. Clinical value of additional resection of a margin-positive distal bile duct in perihilar cholangiocarcinoma. British Journal of Surgery 2019;106:774-82. [DOI: 10.1002/bjs.11125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
97 Ribero D, Amisano M, Lo Tesoriere R, Rosso S, Ferrero A, Capussotti L. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma. Ann Surg. 2011;254:776-81; discussion 781-3. [PMID: 22042470 DOI: 10.1097/sla.0b013e3182368f85] [Cited by in Crossref: 63] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
98 Vern-Gross TZ, Shivnani AT, Chen K, Lee CM, Tward JD, MacDonald OK, Crane CH, Talamonti MS, Munoz LL, Small W. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011;81:189-198. [PMID: 20971573 DOI: 10.1016/j.ijrobp.2010.05.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
99 Onoyama T, Hamamoto W, Sakamoto Y, Kawahara S, Yamashita T, Koda H, Kawata S, Takeda Y, Matsumoto K, Isomoto H. Peroral cholangioscopy-guided forceps biopsy versus fluoroscopy-guided forceps biopsy for extrahepatic biliary lesions. JGH Open 2020;4:1119-27. [PMID: 33319046 DOI: 10.1002/jgh3.12403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Natsume S, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy. Ann Surg. 2012;255:754-762. [PMID: 22367444 DOI: 10.1097/sla.0b013e31824a8d82] [Cited by in Crossref: 67] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
101 Sunkel-Laing B, Kalam A, Renfrew I, Mears L, Kocher HM. Repeated negative biopsies in isolated high-grade cystic duct dysplasia with progression to adenocarcinoma. Case Rep Gastroenterol 2014;8:304-9. [PMID: 25473388 DOI: 10.1159/000368114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Tsukahara T, Shimoyama Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nakamura S, Nagino M. Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern. Mod Pathol 2016;29:293-301. [DOI: 10.1038/modpathol.2015.152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
103 Wakai T, Shirai Y, Hatakeyama K. Peroral cholangioscopy for non-invasive papillary cholangiocarcinoma with extensive superficial ductal spread. World J Gastroenterol 2005; 11(41): 6554-6556 [PMID: 16425434 DOI: 10.3748/wjg.v11.i41.6554] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
104 Sakata J, Shirai Y, Wakai T, Nomura T, Sakata E, Hatakeyama K. Catheter tract implantation metastases associated with percutaneous biliary drainage for extrahepatic cholangiocarcinoma. World J Gastroenterol. 2005;11:7024-7027. [PMID: 16437610 DOI: 10.3748/wjg.v11.i44.7024] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
105 Nakanuma Y, Uchida T, Sato Y, Uesaka K. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma. Hum Pathol. 2017;60:46-57. [PMID: 27984121 DOI: 10.1016/j.humpath.2016.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
106 Kitamura K, Hatano E, Higashi T, Seo S, Nakamoto Y, Narita M, Taura K, Yasuchika K, Nitta T, Yamanaka K, Doi R, Ikai I, Uemoto S. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer. J Hepatobiliary Pancreat Sci 2011;18:39-46. [PMID: 20503059 DOI: 10.1007/s00534-010-0293-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
107 Kim H, Heo MH, Kim JY. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer. BMC Gastroenterol 2020;20:20. [PMID: 31992208 DOI: 10.1186/s12876-020-1171-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Lee EY, Kim C, Kim MJ, Park JY, Park SW, Song SY, Chung JB, Kim H, Bang S. Signet ring cell carcinoma of the extrahepatic bile duct. Gut Liver 2010;4:402-6. [PMID: 20981222 DOI: 10.5009/gnl.2010.4.3.402] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
109 Turaga KK, Tsai S, Wiebe LA, Evans DB, Gamblin TC. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma. Ann Surg Oncol 2013;20:1230-9. [PMID: 23064778 DOI: 10.1245/s10434-012-2648-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
110 Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol. 2007;95:207-212. [PMID: 17278119 DOI: 10.1002/jso.20668] [Cited by in Crossref: 86] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
111 Yoshikawa T, Hakamada K, Ogasawara H, Kimura N, Kudo D, Sakamoto Y, Ishido K, Toyoki Y, Morohashi S, Kijima H. Ex vivo application of endocytoscopy for determining the longitudinal extent of bile duct cancer: a pathological analysis of 28 resected cases. J Hepatobiliary Pancreat Sci 2015;22:58-67. [DOI: 10.1002/jhbp.167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
112 Yoshitomi H, Miyakawa S, Nagino M, Takada T, Miyazaki M. Updated clinical practice guidelines for the management of biliary tract cancers: revision concepts and major revised points. J Hepatobiliary Pancreat Sci 2015;22:274-8. [DOI: 10.1002/jhbp.234] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
113 Khalifa MA. Intraoperative assessment of the Whipple resection specimen. J Clin Pathol 2007;60:975-80. [PMID: 17369506 DOI: 10.1136/jcp.2006.044834] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
114 Onoe S, Shimoyama Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nakamura S, Nagino M. Clinicopathological significance of mucin production in patients with papillary cholangiocarcinoma. World J Surg 2015;39:1177-84. [PMID: 25561191 DOI: 10.1007/s00268-014-2923-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
115 Nagino M, Hirano S, Yoshitomi H, Aoki T, Uesaka K, Unno M, Ebata T, Konishi M, Sano K, Shimada K, Shimizu H, Higuchi R, Wakai T, Isayama H, Okusaka T, Tsuyuguchi T, Hirooka Y, Furuse J, Maguchi H, Suzuki K, Yamazaki H, Kijima H, Yanagisawa A, Yoshida M, Yokoyama Y, Mizuno T, Endo I. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci 2021;28:26-54. [PMID: 33259690 DOI: 10.1002/jhbp.870] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 15.0] [Reference Citation Analysis]
116 Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297-305. [PMID: 22750757 DOI: 10.1097/sla.0b013e31826029ca] [Cited by in Crossref: 129] [Cited by in F6Publishing: 37] [Article Influence: 12.9] [Reference Citation Analysis]
117 Howell M, Valle JW. The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015;29:333-43. [PMID: 25966432 DOI: 10.1016/j.bpg.2015.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
118 Aoyama H, Ebata T, Hattori M, Takano M, Yamamoto H, Inoue M, Asaba Y, Ando M, Nagino M, Aoba T, Kaneoka Y, Arai T, Shimizu Y, Kiriyama M, Sakamoto E, Miyake H, Takara D, Shirai K, Ohira S, Kobayashi S, Kato Y, Yamaguchi R, Hayashi E, Miyake T, Mizuno S, Sato T, Suzuki K, Hashimoto M, Kawai S, Matsubara H, Kato K, Yokoyama S, Suzumura K; Nagoya Surgical Oncology Group. Reappraisal of classification of distal cholangiocarcinoma based on tumour depth. British Journal of Surgery 2018;105:867-75. [DOI: 10.1002/bjs.10869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
119 Shingu Y, Ebata T, Nishio H, Igami T, Shimoyama Y, Nagino M. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery. 2010;147:49-56. [PMID: 19767048 DOI: 10.1016/j.surg.2009.06.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
120 Senda Y, Nishio H, Oda K, Yokoyama Y, Ebata T, Igami T, Sugiura T, Shimoyama Y, Nimura Y, Nagino M. Value of multidetector row CT in the assessment of longitudinal extension of cholangiocarcinoma: correlation between MDCT and microscopic findings. World J Surg. 2009;33:1459-1467. [PMID: 19381719 DOI: 10.1007/s00268-009-0025-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
121 Kingham TP, Aveson VG, Wei AC, Castellanos JA, Allen PJ, Nussbaum DP, Hu Y, D'Angelica MI. Surgical management of biliary malignancy. Curr Probl Surg 2021;58:100854. [PMID: 33531120 DOI: 10.1016/j.cpsurg.2020.100854] [Reference Citation Analysis]
122 Sakata J, Wakai T, Matsuda Y, Ohashi T, Hirose Y, Ichikawa H, Kobayashi T, Minagawa M, Kosugi S, Koyama Y, Akazawa K, Ajioka Y. Comparison of Number Versus Ratio of Positive Lymph Nodes in the Assessment of Lymph Node Status in Extrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2016;23:225-234. [PMID: 25994208 DOI: 10.1245/s10434-015-4609-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
123 Ebata T, Kosuge T, Hirano S, Unno M, Yamamoto M, Miyazaki M, Kokudo N, Miyagawa S, Takada T, Nagino M. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg. 2014;101:79-88. [PMID: 24375300 DOI: 10.1002/bjs.9379] [Cited by in Crossref: 84] [Cited by in F6Publishing: 122] [Article Influence: 10.5] [Reference Citation Analysis]
124 Moslim MA, Tang A, Morris-Stiff G. Management of high-grade dysplasia of the cystic duct after cholecystectomy. BMJ Case Rep 2017;2017:bcr-2016-218994. [PMID: 28645922 DOI: 10.1136/bcr-2016-218994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
125 Addeo P, Oussoultzoglou E, Fuchshuber P, Rosso E, Nobili C, Langella S, Jaeck D, Bachellier P. Safety and outcome of combined liver and pancreatic resections. British Journal of Surgery 2014;101:693-700. [DOI: 10.1002/bjs.9443] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
126 Oh D, Lim DH, Heo JS, Choi SH, Choi DW, Ahn YC, Park W, Huh SJ. The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery. Am J Clin Oncol. 2007;30:21-25. [PMID: 17278890 DOI: 10.1097/01.coc.0000245467.97180.78] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
127 Lee JH, Hwang DW, Lee SY, Park K, Lee Y. The Proximal Margin of Resected Hilar Cholangiocarcinoma: The Effect of Microscopic Positive Margin on Long-Term Survival. The American Surgeon 2012;78:471-7. [DOI: 10.1177/000313481207800440] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
128 Akita M, Ajiki T, Ueno K, Tsugawa D, Tanaka M, Kido M, Toyama H, Fukumoto T. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2020;19:147-52. [PMID: 32037277 DOI: 10.1016/j.hbpd.2020.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Hwang S, Lee SG, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH. Extended extrahepatic bile duct resection to avoid performing pancreatoduodenectomy in patients with mid bile duct cancer. Dig Surg. 2008;25:74-79. [PMID: 18292664 DOI: 10.1159/000118025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
130 Kimura N, Toyoki Y, Ishido K, Kudo D, Yakoshi Y, Tsutsumi S, Miura T, Wakiya T, Hakamada K. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma. J Gastrointest Surg 2015;19:866-79. [PMID: 25605416 DOI: 10.1007/s11605-014-2741-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
131 Onoyama T, Hamamoto W, Sakamoto Y, Kawahara S, Yamashita T, Koda H, Kawata S, Takeda Y, Matsumoto K, Isomoto H. Peroral Cholangioscopy-Guided Forceps Mapping Biopsy for Evaluation of the Lateral Extension of Biliary Tract Cancer. J Clin Med 2021;10:597. [PMID: 33562535 DOI: 10.3390/jcm10040597] [Reference Citation Analysis]
132 Onoyama T, Takeda Y, Kawata S, Kurumi H, Koda H, Yamashita T, Hamamoto W, Sakamoto Y, Matsumoto K, Isomoto H. Adequate tissue acquisition rate of peroral cholangioscopy-guided forceps biopsy. Ann Transl Med 2020;8:1073. [PMID: 33145292 DOI: 10.21037/atm-20-2738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. British Journal of Surgery 2010;97:1363-8. [DOI: 10.1002/bjs.7122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
134 Kurahara H, Maemura K, Mataki Y, Sakoda M, Iino S, Kawasaki Y, Mori S, Kijima Y, Ueno S, Shinchi H, Takao S, Natsugoe S. Relationship between the surgical margin status, prognosis, and recurrence in extrahepatic bile duct cancer patients. Langenbecks Arch Surg 2017;402:87-93. [PMID: 27491729 DOI: 10.1007/s00423-016-1491-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
135 Iinuma Y, Yokoyama N, Saikusa N, Hashidate H, Naito S, Hirayama Y, Nakaya K, Nitta K. A long-term survivor after radical surgery in early childhood for biliary tract cancer associated with congenital biliary dilatation despite a positive margin for epithelial carcinoma. Journal of Pediatric Surgery Case Reports 2022;79:102211. [DOI: 10.1016/j.epsc.2022.102211] [Reference Citation Analysis]
136 Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008;15:41-54. [PMID: 18274843 DOI: 10.1007/s00534-007-1279-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 9.8] [Reference Citation Analysis]
137 Noji T, Okamura K, Tanaka K, Nakanishi Y, Asano T, Nakamura T, Tsuchikawa T, Hirano S. Surgical technique and results of intrapancreatic bile duct resection for hilar malignancy (with video). HPB (Oxford) 2018;20:1145-9. [PMID: 29941288 DOI: 10.1016/j.hpb.2018.05.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
138 Sano T, Shimada K, Sakamoto Y, Esaki M, Kosuge T. Changing trends in surgical outcomes after major hepatobiliary resection for hilar cholangiocarcinoma: a single-center experience over 25 years. J Hepatobiliary Pancreat Surg. 2007;14:455-462. [PMID: 17909713 DOI: 10.1007/s00534-006-1194-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
139 Matthaei H, Lingohr P, Strässer A, Dietrich D, Rostamzadeh B, Glees S, Roering M, Möhring P, Scheerbaum M, Stoffels B. Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications. Virchows Arch. 2015;466:133-141. [PMID: 25425476 DOI: 10.1007/s00428-014-1689-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
140 Matono R, Ninomiya M, Morita K, Tomino T, Oshiro Y, Yokota T, Nishizaki T. Branch-type intraductal papillary neoplasm of the bile duct treated with laparoscopic anatomical resection: a case report. Surg Case Rep. 2020;6:103. [PMID: 32415464 DOI: 10.1186/s40792-020-00864-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
141 Moreau J, Lapeyre M, Benoit C, Pezet D, Biau J. [Intra and extra hepatic cholangiocarcinomas radiation therapy]. Cancer Radiother 2021;25:175-81. [PMID: 33423966 DOI: 10.1016/j.canrad.2020.06.039] [Reference Citation Analysis]
142 Iso Y, Kita J, Kato M, Shimoda M, Kubota K. When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma. Med Sci Monit 2014;20:471-5. [PMID: 24657986 DOI: 10.12659/MSM.889714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
143 Zaydfudim VM, Clark CJ, Kendrick ML, Que FG, Reid-Lombardo KM, Donohue JH, Farnell MB, Nagorney DM. Correlation of staging systems to survival in patients with resected hilar cholangiocarcinoma. Am J Surg 2013;206:159-65. [PMID: 23746658 DOI: 10.1016/j.amjsurg.2012.11.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
144 Uemura S, Higuchi R, Yazawa T, Izumo W, Matsunaga Y, Shiihara M, Ota T, Furukawa T, Yamamoto M. Prognostic Factors for Surgically Resected Intraductal Papillary Neoplasm of the Bile Duct: A Retrospective Cohort Study. Ann Surg Oncol. 2021;28:826-834. [PMID: 32651697 DOI: 10.1245/s10434-020-08835-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
145 Sasaki T, Kondo S, Ambo Y, Hirano S, Sichinohe T, Kaga K, Sugiura H, Shimozawa E. Local recurrence at hepaticojejunostomy 9 years after resection of bile duct cancer with superficial flat spread. J Hepatobiliary Pancreat Surg 2006;13:458-62. [DOI: 10.1007/s00534-005-1096-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
146 Oguro S, Esaki M, Kishi Y, Nara S, Shimada K, Ojima H, Kosuge T. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma. Ann Surg Oncol 2015;22:1915-24. [PMID: 25404474 DOI: 10.1245/s10434-014-4232-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
147 Sano T, Shimizu Y, Senda Y, Komori K, Ito S, Abe T, Kinoshita T, Nimura Y. Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg 2013;398:1145-50. [PMID: 24026222 DOI: 10.1007/s00423-013-1110-5] [Reference Citation Analysis]
148 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Nakagawa N, Muto T, Sasaki H, Urabe K, Sueda T. Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. J Gastrointest Surg. 2013;17:1429-1439. [PMID: 23797881 DOI: 10.1007/s11605-013-2251-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
149 Onoe S, Shimoyama Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nakamura S, Nagino M. Prognostic delineation of papillary cholangiocarcinoma based on the invasive proportion: a single-institution study with 184 patients. Surgery. 2014;155:280-291. [PMID: 24287144 DOI: 10.1016/j.surg.2013.08.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
150 Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol 2008;15:590-9. [PMID: 18057991 DOI: 10.1245/s10434-007-9687-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
151 Nakahashi K, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Onoe S, Watanabe N, Nagino M. How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma? Surgery 2020;168:617-24. [PMID: 32665142 DOI: 10.1016/j.surg.2020.04.068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Yao S, Taura K, Okuda Y, Kodama Y, Uza N, Gouda N, Minamiguchi S, Okajima H, Kaido T, Uemoto S. Effect of mapping biopsy on surgical management of cholangiocarcinoma: YAO et al.. J Surg Oncol 2018;118:997-1005. [DOI: 10.1002/jso.25226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
153 Ahn KS, Kang KJ, Kang YN, Kim YH, Kim TS. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma. BMC Gastroenterol 2016;16:21. [PMID: 26911927 DOI: 10.1186/s12876-016-0444-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
154 Koo T, Park HJ, Kim K. Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives. World J Clin Cases 2019; 7(11): 1242-1252 [PMID: 31236388 DOI: 10.12998/wjcc.v7.i11.1242] [Reference Citation Analysis]
155 Matsuyama R, Morioka D, Mori R, Yabushita Y, Hiratani S, Ota Y, Kumamoto T, Endo I. Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma. World J Surg 2019;43:1094-104. [PMID: 30536024 DOI: 10.1007/s00268-018-04883-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
156 Han IW, Jang JY, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection. Ann Surg Treat Res 2014;87:87-93. [PMID: 25114888 DOI: 10.4174/astr.2014.87.2.87] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]